SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
7.78
+0.22 (2.91%)
At close: May 22, 2026, 4:00 PM EDT
7.79
+0.01 (0.13%)
After-hours: May 22, 2026, 7:58 PM EDT
SLS Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$10.00
Upside
+28.53%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $7 → $10 | Strong Buy | Maintains | $7 → $10 | +28.53% | Mar 12, 2026 |
| Maxim Group | Maxim Group | Strong Buy Maintains $4 → $7 | Strong Buy | Maintains | $4 → $7 | -10.03% | Jul 16, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $3 | Buy | Reiterates | $3 | -61.44% | Nov 22, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $3 | Buy | Reiterates | $3 | -61.44% | Sep 7, 2023 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $14 → $8 | Strong Buy | Maintains | $14 → $8 | +2.83% | Nov 15, 2022 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $10 → $6 | Buy | Maintains | $10 → $6 | -22.88% | Jun 28, 2022 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $18 | Buy | Initiates | $18 | +131.36% | Jul 21, 2021 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $12 | Hold → Strong Buy | Upgrades | $12 | +54.24% | Nov 15, 2019 |
| Oppenheimer | Oppenheimer | Buy Initiates $650 | Buy | Initiates | $650 | +8,254.76% | Nov 1, 2018 |
| Maxim Group | Maxim Group | Strong Buy Maintains $650 → $250 | Strong Buy | Maintains | $650 → $250 | +3,113.37% | Jul 20, 2018 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Mar 19, 2018 |